Viridian Therapeutics, Inc. <VRDN.O>: RBC raises target price to $38 from $36
VRDN•Related News
RxSight <RXST.O>: BofA Global Research cuts price objective to $5.50 from $6.50
RXST•
Critics say California got too little in deal to let Paramount buy Warner Bros
PSKY•
Nasdaq trade halt continues <VWAV.O> reason not available at 04:00 AM
VWAV•
Comstock Metals starts 24/7 solar panel recycling operations at Silver Springs, Nevada facility
LODE•
Tyra Biosciences, Inc. <TYRA.O>: H.C. Wainwright cuts target price to $29 from $30
TYRA•